107 related articles for article (PubMed ID: 38748880)
1. Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses.
Liu C; Xu S; Zheng Y; Xie Y; Xu K; Chai Y; Luo T; Dai L; Gao GF
Cell Rep; 2024 May; 43(5):114235. PubMed ID: 38748880
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
Fan C; Cohen AA; Park M; Hung AF; Keeffe JR; Gnanapragasam PNP; Lee YE; Gao H; Kakutani LM; Wu Z; Kleanthous H; Malecek KE; Williams JC; Bjorkman PJ
Immunity; 2022 Dec; 55(12):2419-2435.e10. PubMed ID: 36370711
[TBL] [Abstract][Full Text] [Related]
3. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
Cohen AA; Gnanapragasam PNP; Lee YE; Hoffman PR; Ou S; Kakutani LM; Keeffe JR; Wu HJ; Howarth M; West AP; Barnes CO; Nussenzweig MC; Bjorkman PJ
Science; 2021 Feb; 371(6530):735-741. PubMed ID: 33436524
[TBL] [Abstract][Full Text] [Related]
4. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
Cohen AA; van Doremalen N; Greaney AJ; Andersen H; Sharma A; Starr TN; Keeffe JR; Fan C; Schulz JE; Gnanapragasam PNP; Kakutani LM; West AP; Saturday G; Lee YE; Gao H; Jette CA; Lewis MG; Tan TK; Townsend AR; Bloom JD; Munster VJ; Bjorkman PJ
Science; 2022 Aug; 377(6606):eabq0839. PubMed ID: 35857620
[TBL] [Abstract][Full Text] [Related]
5. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
Cell Rep; 2021 Sep; 36(13):109760. PubMed ID: 34534459
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
Starr TN; Czudnochowski N; Liu Z; Zatta F; Park YJ; Addetia A; Pinto D; Beltramello M; Hernandez P; Greaney AJ; Marzi R; Glass WG; Zhang I; Dingens AS; Bowen JE; Tortorici MA; Walls AC; Wojcechowskyj JA; De Marco A; Rosen LE; Zhou J; Montiel-Ruiz M; Kaiser H; Dillen JR; Tucker H; Bassi J; Silacci-Fregni C; Housley MP; di Iulio J; Lombardo G; Agostini M; Sprugasci N; Culap K; Jaconi S; Meury M; Dellota E; Abdelnabi R; Foo SC; Cameroni E; Stumpf S; Croll TI; Nix JC; Havenar-Daughton C; Piccoli L; Benigni F; Neyts J; Telenti A; Lempp FA; Pizzuto MS; Chodera JD; Hebner CM; Virgin HW; Whelan SPJ; Veesler D; Corti D; Bloom JD; Snell G
Nature; 2021 Sep; 597(7874):97-102. PubMed ID: 34261126
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
[TBL] [Abstract][Full Text] [Related]
8. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Walls AC; Fiala B; Schäfer A; Wrenn S; Pham MN; Murphy M; Tse LV; Shehata L; O'Connor MA; Chen C; Navarro MJ; Miranda MC; Pettie D; Ravichandran R; Kraft JC; Ogohara C; Palser A; Chalk S; Lee EC; Guerriero K; Kepl E; Chow CM; Sydeman C; Hodge EA; Brown B; Fuller JT; Dinnon KH; Gralinski LE; Leist SR; Gully KL; Lewis TB; Guttman M; Chu HY; Lee KK; Fuller DH; Baric RS; Kellam P; Carter L; Pepper M; Sheahan TP; Veesler D; King NP
Cell; 2020 Nov; 183(5):1367-1382.e17. PubMed ID: 33160446
[TBL] [Abstract][Full Text] [Related]
9. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
[TBL] [Abstract][Full Text] [Related]
10. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
12. Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein.
Xu S; Wang Y; Wang Y; Zhang C; Hong Q; Gu C; Xu R; Wang T; Yang Y; Zang J; Zhou Y; Li Z; Liu Q; Zhou B; Bai L; Zhu Y; Deng Q; Wang H; Lavillette D; Wong G; Xie Y; Cong Y; Huang Z
Emerg Microbes Infect; 2022 Dec; 11(1):351-367. PubMed ID: 34964428
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants.
Zakir TS; Meng T; Carmen LCP; Chu JJH; Lin RTP; Prabakaran M
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215823
[TBL] [Abstract][Full Text] [Related]
15. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Scheid JF; Barnes CO; Eraslan B; Hudak A; Keeffe JR; Cosimi LA; Brown EM; Muecksch F; Weisblum Y; Zhang S; Delorey T; Woolley AE; Ghantous F; Park SM; Phillips D; Tusi B; Huey-Tubman KE; Cohen AA; Gnanapragasam PNP; Rzasa K; Hatziioanno T; Durney MA; Gu X; Tada T; Landau NR; West AP; Rozenblatt-Rosen O; Seaman MS; Baden LR; Graham DB; Deguine J; Bieniasz PD; Regev A; Hung D; Bjorkman PJ; Xavier RJ
Cell; 2021 Jun; 184(12):3205-3221.e24. PubMed ID: 34015271
[TBL] [Abstract][Full Text] [Related]
16. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
Martinez DR; Schäfer A; Leist SR; De la Cruz G; West A; Atochina-Vasserman EN; Lindesmith LC; Pardi N; Parks R; Barr M; Li D; Yount B; Saunders KO; Weissman D; Haynes BF; Montgomery SA; Baric RS
Science; 2021 Aug; 373(6558):991-998. PubMed ID: 34214046
[TBL] [Abstract][Full Text] [Related]
17. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
[TBL] [Abstract][Full Text] [Related]
18. Designed mosaic nanoparticles enhance cross-reactive immune responses in mice.
Wang E; Cohen AA; Caldera LF; Keeffe JR; Rorick AV; Aida YM; Gnanapragasam PNP; Bjorkman PJ; Chakraborty AK
bioRxiv; 2024 Feb; ():. PubMed ID: 38464322
[TBL] [Abstract][Full Text] [Related]
19. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals.
Cohen AA; Keeffe JR; Schiepers A; Dross SE; Greaney AJ; Rorick AV; Gao H; Gnanapragasam PNP; Fan C; West AP; Ramsingh AI; Erasmus JH; Pata JD; Muramatsu H; Pardi N; Lin PJC; Baxter S; Cruz R; Quintanar-Audelo M; Robb E; Serrano-Amatriain C; Magneschi L; Fotheringham IG; Fuller DH; Victora GD; Bjorkman PJ
bioRxiv; 2024 May; ():. PubMed ID: 38370696
[TBL] [Abstract][Full Text] [Related]
20. Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models.
Cohen AA; van Doremalen N; Greaney AJ; Andersen H; Sharma A; Starr TN; Keeffe JR; Fan C; Schulz JE; Gnanapragasam PNP; Kakutani LM; West AP; Saturday G; Lee YE; Gao H; Jette CA; Lewis MG; Tan TK; Townsend AR; Bloom JD; Munster VJ; Bjorkman PJ
bioRxiv; 2022 Mar; ():. PubMed ID: 35378752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
